Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Valproic acid (VPA) is an anti-epileptic drug that has been associated with polycystic ovary syndrome (PCOS)-like symptoms, including increased ovarian androgen production. The hyperandrogenemia likely reflects the stimulatory action of VPA on theca cell androgen synthesis and has been correlated to its activity as a histone deacteylase inhibitor in these cells. To determine whether VPA induces a PCOS-like genomic phenotype, we compared the gene expression profiles of untreated (UNT) normal, VPA-treated normal, and UNT PCOS theca cells. Hierarchal cluster analysis demonstrated similarities in the gene expression profiles of VPA-treated normal and PCOS theca cells. Statistical analysis identified 1,050 transcripts that have significantly altered mRNA abundance in both VPA-treated normal and UNT PCOS theca cells compared with normal UNT theca cells. Among these 1,050 transcripts were cAMP-GEFII and TRB3, which have increased and decreased mRNA abundance, respectively. The altered abundance of these two mRNAs was correlated to increased basal and insulin-induced phosphorylation of protein kinase B (Akt/PKB). Thus these studies indicate that VPA- and PCOS-induced changes in gene expression enhance Akt/PKB signal transduction in human theca cells. Furthermore, common changes in gene expression in PCOS and VPA-treated normal theca cells suggest a possible mechanism for the development of PCOS-like symptoms, including increased steroid synthesis and arrested follicle development in women receiving chronic VPA therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758 · cited 3×
“VPA reversibly inhibits the catalytic activity of class I HDACs, resulting in increased acetylation of histones and leading to altered expression of target genes (17, 36).”
BackgroundTRB3: A tribbles Homolog That Inhibits Akt/PKB Activation by Insulin in Liver
Du, K., Herzig, S., Kulkarni, R. N., & Montminy, M. (2003) · Science · doi:10.1126/science.1079817 · Cited by 842 · cited 3×
“TRB3 regulates glucose metabolism in hepatic cells, and cAMP-GEFII is a component of the insulin secretory pathway in pancreatic -cells (12, 21, 22).”
BackgroundNelson, V. L., Legro, R. S., Strauss, J. F., & McAllister, J. M. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0311 · Cited by 556
Self-citationPGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3
Koo, S.-H., Satoh, H., Herzig, S., Lee, C.-H., Hedrick, S., Kulkarni, R., Evans, R. M., Olefsky, J., & Montminy, M. (2004) · Nature Medicine · doi:10.1038/nm1044 · Cited by 550
Geller, D. H., Auchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0219 · Cited by 183 · cited 5×
“One explanation for these data is that the theca cells were not stimulated with forskolin, resulting in levels of CYP17 and CYP11A mRNA that are below the sensitivity of the Affymetrix oligonucleotide probe set used in the analysis.”
BackgroundInfluential
Cited by
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Wood, J. R., Dumesic, D. A., Abbott, D. H., & Strauss, J. F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2123 · Cited by 306
Self-citationGenetic determinants of polycystic ovary syndrome: Progress and future directions
Jones, M. R., & Goodarzi, M. O. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.04.040 · Cited by 117
Mohamed-Hussein, Z.-A., & Harun, S. (2009) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-6-18 · Cited by 46
Metadata
- Authors
- Wood, J. R., Nelson-Degrave, V. L., Jansen, E., McAllister, J. M., Mosselman, S., & Strauss, J. F.
- Venue
- Physiological Genomics
- Publisher
- American Physiological Society
- Published
- 2005-02-10
- Volume
- 20
- Issue
- 3
- Pages
- 233-243
- ISSN
- 1094-8341 (ISSN-L)
- 1531-2267
- OpenAlex
- W2120005154
- Cited by
- 78
- References
- 6
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects. https://app.cochat.ai/papers/10.1152/physiolgenomics.00193.2004
- The paper
- Wood, J. R., Nelson-Degrave, V. L., Jansen, E., McAllister, J. M., Mosselman, S., & Strauss, J. F. (2005). Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects. Physiological Genomics. https://doi.org/10.1152/physiolgenomics.00193.2004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.